Effect of serum uric acid (ua) level and MASCC risk score on febrile neutropenia mortality

被引：0
|
作者：
Sutcuoglu, O. [1 ]
Akdogan, O. [2 ]
Inci, B. Kurt [3 ]
Gurler, F. [1 ]
Yildirim, N. Ozdemir [1 ]
Yazici, O. [1 ]
机构：
[1] Gazi Univ, Fac Med, Med Oncol, Ankara, Turkey
[2] Gazi Univ, Fac Med, Internal Med, Ankara, Turkey
[3] Gazi Univ, Fac Med, Med Oncol Dept, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1482
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1835P
引用
收藏
页码：S1055 / S1055
页数：1
相关论文
共 50 条
  • [1] Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality
    Osman Sütcüoğlu
    Orhun Akdoğan
    Bediz Kurt İnci
    Fatih Gürler
    Nuriye Özdemir
    Ozan Yazıcı
    Supportive Care in Cancer, 2021, 29 : 1047 - 1053
  • [2] Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality
    Sutcuoglu, Osman
    Akdogan, Orhun
    Inci, Bediz Kurt
    Gurler, Fatih
    ozdemir, Nuriye
    Yazici, Ozan
    SUPPORTIVE CARE IN CANCER, 2021, 29 (02) : 1047 - 1053
  • [3] Effect of serum albumin/globulin ratio in combination with MASCC and CISNE risk score on febrile neutropenia mortality
    Yazici, O.
    Sutcuoglu, O.
    Akdogan, O.
    Inci, B. Kurt
    Gurler, F.
    Yildirim, N. Ozdemir
    ANNALS OF ONCOLOGY, 2020, 31 : S1053 - S1053
  • [4] The predictive value of the MASCC score in patients with febrile neutropenia
    Anderson, Zackary
    Plowman, Keegan
    Ahsan, Mohammed
    Rasnake, Mark
    Kubiak, Michal J.
    Grossman, Joel Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia
    M. Taj
    M. Nadeem
    S. Maqsood
    T. Shah
    T. Farzana
    T. S. Shamsi
    Indian Journal of Hematology and Blood Transfusion, 2017, 33 : 355 - 360
  • [6] Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia
    Taj, M.
    Nadeem, M.
    Maqsood, S.
    Shah, T.
    Farzana, T.
    Shamsi, T. S.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (03) : 355 - 360
  • [7] Prognosis prediction of febrile neutropenia by MASCC score: A retrospective study
    Cervetti, Louise
    Vallard, Alexis
    Le Moulec, Sylvestre
    Espenel, Sophie
    Falk, Alexander Tuan
    Ben Mrad, Majed
    Guy, Jean-Baptiste
    Diao, Peng
    Mery, Benoite
    Langrand-Escure, Julien
    Ferrand, Francois-Regis
    Rivoirard, Romain
    Ceccaldi, Bernard
    Vedrine, Lionel
    Magne, Nicolas
    Chargari, Cyrus
    BULLETIN DU CANCER, 2016, 103 (06) : 561 - 570
  • [8] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Shin Ahn
    Yoon-Seon Lee
    Kyung Soo Lim
    Jae-Lyun Lee
    Supportive Care in Cancer, 2013, 21 : 2303 - 2308
  • [9] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Lim, Kyung Soo
    Lee, Jae-Lyun
    SUPPORTIVE CARE IN CANCER, 2013, 21 (08) : 2303 - 2308
  • [10] Risk scores for outpatient management of febrile neutropenia: Is the MASCC slipping?
    Cooksley, Tim
    Ahn, Shin
    Knight, Thomas
    Rice, Terry W.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 50 : E35 - E36
12345